| Literature DB >> 36061507 |
Victor Hugo Calegari de Toledo1,2, Arthur Sant'Anna Feltrin3, André Rocha Barbosa4, Ana Carolina Tahira5, Helena Brentani1,2.
Abstract
Neurodevelopmental disorders differ considerably between males and females, and fetal brain development is one of the most critical periods to determine risk for these disorders. Transcriptomic studies comparing male and female fetal brain have demonstrated that the highest difference in gene expression occurs in sex chromosomes, but several autossomal genes also demonstrate a slight difference that has not been yet explored. In order to investigate biological pathways underlying fetal brain sex differences, we applied medicine network principles using integrative methods such as co-expression networks (CEMiTool) and regulatory networks (netZoo). The pattern of gene expression from genes in the same pathway tend to reflect biologically relevant phenomena. In this study, network analysis of fetal brain expression reveals regulatory differences between males and females. Integrating two different bioinformatics tools, our results suggest that biological processes such as cell cycle, cell differentiation, energy metabolism and extracellular matrix organization are consistently sex-biased. MSET analysis demonstrates that these differences are relevant to neurodevelopmental disorders, including autism.Entities:
Keywords: autism spectrum disorder (ASD); fetal brain development; gene regulatory networks; neurodevelopmental disorders; sex differences; systems biology
Year: 2022 PMID: 36061507 PMCID: PMC9428411 DOI: 10.3389/fnhum.2022.955607
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.473
Figure 1Workflow of the analyses that were carried out using CEMiTool and netZoo with male and female RNAseq data from fetal brain samples.
Figure 2Normalized expression values from males and females were submitted to co-expression analysis with CEMiTool, demonstrating different patterns of expression associated with particular biological functions. (A) GSEA demonstrating each module activity for males and females. Circle color and size represents the Normalized Enrichment Score (NES). (B) Integrated network with interaction data for M9, with hub genes highlighted. (C) Over-representation analysis of genes from module M9 using pathways from the Reactome database.
Figure 3GO terms enrichment of modules from female-baseline differential network resulted from ALPACA analysis of differences in network topology from PANDA networks. GO terms were chosen according to their uniqueness, dispensability and significance based on REVIGO analysis. The color of the circle indicates the over-representation adjusted p-value, and the size represents the number of genes corresponding to the GO term.
Figure 4Enrichment of modules from the male-baseline differential network for GO terms selected by REVIGO. The intensity of the color of the circle indicates the over-representation adjusted p-value, and the size represents the number of genes corresponding to the GO term.
Male-biased TFs and genes with the highest contribution to differential modularity.
|
|
|
|
|
|
|---|---|---|---|---|
| ETV1 | 0.111032711911787 | TF | 7 | –2.19793041917789 |
| ETV3 | 0.105102133884857 | TF | 7 | –2.25282269792897 |
| ENSG00000235187 | 0.101989495776801 | TF | 7 | –2.28288545358132 |
| ELK1 | 0.100036227836841 | TF | 7 | –2.3022228802326 |
| ERF | 0.0942194013630829 | TF | 7 | –2.36212915933812 |
| GABPA | 0.0921935111193238 | TF | 7 | –2.38386552921162 |
| ERG | 0.084327581715349 | TF | 7 | –2.47304628225229 |
| ELK4 | 0.0820083882832545 | TF | 7 | –2.50093374081253 |
| ELF4 | 0.0719844617675763 | TF | 7 | –2.63130499203981 |
| ETV2 | 0.0623491141159714 | TF | 7 | –2.77500581520127 |
| ETV6 | 0.0460089254404356 | TF | 7 | –3.07891987000087 |
| NFYB | 0.0454872742240467 | TF | 6 | –3.09032267952863 |
| NFYC | 0.0448559588330572 | TF | 6 | –3.10429883791896 |
| CREB3 | 0.0444155913215513 | TF | 6 | –3.11416471529396 |
| PBX3 | 0.0439291433374868 | TF | 6 | –3.12517732181088 |
| CEBPZ | 0.0411715669742121 | TF | 6 | –3.19000738285559 |
| FOXI1 | 0.0411560241502577 | TF | 6 | –3.19038496767076 |
| ATF7 | 0.0407077302738889 | TF | 6 | –3.2013372715492 |
| NFYA | 0.040400432360089 | TF | 6 | –3.2089147920899 |
| CREM | 0.04007506050778 | TF | 6 | –3.21700107062415 |
| CREB1 | 0.0397179861278367 | TF | 6 | –3.22595114280664 |
| ATF1 | 0.039205356293987 | TF | 6 | –3.23894190136741 |
| CREB5 | 0.0384335142390451 | TF | 6 | –3.25882543338601 |
| ATF2 | 0.0375351526625051 | TF | 6 | –3.28247738076136 |
| SARS2 | 0.00667974832348833 | Gene | 6 | –5.00867496826785 |
| SCNM1 | 0.00610836004776335 | Gene | 7 | –5.09809694644698 |
| SF3A1 | 0.00580643130286095 | Gene | 7 | –5.1487891304238 |
Female-biased TFs with the highest scores of differential modularity.
|
|
|
|
|
|
|---|---|---|---|---|
| GSC | 0.15269444991972 | TF | 9 | –1.87931641371986 |
| DMBX1 | 0.143896164185085 | TF | 9 | –1.93866332155886 |
| PITX3 | 0.139609591555273 | TF | 9 | –1.96890538359812 |
| GSC2 | 0.136565488213182 | TF | 9 | –1.99095101227904 |
| PITX1 | 0.129696540209988 | TF | 9 | –2.0425578633433 |
| CRX | 0.125931486465048 | TF | 9 | –2.07201727813467 |
| ATF7 | 0.123740411331103 | TF | 7 | –2.0895693647285 |
| CREB3 | 0.120790690784687 | TF | 7 | –2.1136960594916 |
| DPRX | 0.120072842470422 | TF | 9 | –2.11965669977571 |
| CREB1 | 0.114068478575226 | TF | 7 | –2.17095632167285 |
| ATF2 | 0.111667400013813 | TF | 7 | –2.19223046855887 |
| CREB5 | 0.110148933472246 | TF | 7 | –2.2059218882841 |
| BHLHE23 | 0.108192582807058 | TF | 5 | –2.22384246568603 |
| BHLHA15 | 0.107423375532402 | TF | 5 | –2.23097747131205 |
| OLIG1 | 0.103916814738681 | TF | 5 | –2.26416455817999 |
| OLIG2 | 0.100935892899876 | TF | 5 | –2.29326968742689 |
| OLIG3 | 0.0992507778721316 | TF | 5 | –2.31010552194296 |
| CREM | 0.0973928687453972 | TF | 7 | –2.32900228718044 |
| ATF1 | 0.0965080136608328 | TF | 7 | –2.33812923096765 |
| E4F1 | 0.0948727792385772 | TF | 7 | –2.35521845077532 |
| NEUROD2 | 0.0901541681065749 | TF | 5 | –2.40623409516508 |
| BHLHE22 | 0.0877130213855779 | TF | 5 | –2.43368491416513 |
| NEUROG1 | 0.0863604773712158 | TF | 5 | –2.44922514566188 |
| NEUROG2 | 0.0858153611956347 | TF | 5 | –2.4555572535989 |
| BATF3 | 0.0752807014700203 | TF | 7 | –2.58653146560257 |
| ETV1 | 0.0736046279099473 | TF | 8 | –2.60904737601288 |
| ETV3 | 0.0732706608698659 | TF | 8 | –2.61359501119943 |
| ENSG00000235187 | 0.0728467393263581 | TF | 8 | –2.61939750607484 |
| ELK1 | 0.0726022269170718 | TF | 8 | –2.62275968383295 |
| TCF23 | 0.0677728510262973 | TF | 5 | –2.69159359156897 |
| ERF | 0.0659989002319932 | TF | 8 | –2.71811720024616 |
| GABPA | 0.0653488923062923 | TF | 8 | –2.72801478922706 |
| TWIST2 | 0.06246467706455 | TF | 5 | –2.77315404897403 |
| ERG | 0.0577576316972216 | TF | 8 | –2.85149978771012 |
| ELK4 | 0.0572357326313101 | TF | 8 | –2.86057687928635 |
| MNT | 0.0557028778394643 | TF | 3 | –2.88772346660684 |
| JUN | 0.0555297227080979 | TF | 7 | –2.89083685729236 |
| MLXIP | 0.0541104351118061 | TF | 3 | –2.9167282261141 |
| ELF4 | 0.0533629664474969 | TF | 8 | –2.93063828582599 |
| ID2 | 0.0516803037243714 | TF | 3 | –2.96267854250549 |
| OTX1 | 0.0515334369812805 | TF | 9 | –2.96552442021925 |
| NPAS2 | 0.0510333269816641 | TF | 3 | –2.9752763894478 |
| MXI1 | 0.0479890121591645 | TF | 3 | –3.03678320762965 |
| MYCL1 | 0.0457721650316248 | TF | 3 | –3.08407912301834 |
| MYCN | 0.0446185170191288 | TF | 3 | –3.10960632631831 |
| ETV2 | 0.0398554499721332 | TF | 8 | –3.22249612093557 |
| ELF1 | 0.0391257977816137 | TF | 8 | –3.24097323974533 |
| MYC | 0.0381768714055192 | TF | 3 | –3.26552540732339 |
| HEY1 | 0.0381381103891828 | TF | 3 | –3.26654122410688 |
| BHLHE40 | 0.037927235388315 | TF | 3 | –3.27208581314271 |
Figure 5MSET analysis of all genes from differential modules for enrichment of mid-gestational cell types identified by fetal brain single-cell RNA-seq. (A) MSET analysis of genes from differential modules using the female network as the baseline. Circle size indicates module gene fold enrichment of the cell type dataset and significant enrichment (adjusted p < 0.05) is represented by the red scaled colors. (B) Cell type results using the male differential network.
Figure 6Enrichment analysis using MSET to identify differential modules with genes associated with neuropsychiatric disorders lists from multiple databases (see Methods). (A) Disorders to which female-baseline differential modules are significantly enriched are represented by red scaled circles (adjusted p < 0.05). Circle size is relative to the fold enrichment. (B) Enrichment of male-baseline differential modules to disorders databases.